Martin Weltman - Concepedia

Author

Martin Weltman

Also Known As

Bo Wang, M D Weltman, M WELTMAN, M Weltman, M. D. Weltman, M. Weltman, M.D. Weltman, MARTIN WELTMAN, Maria Christine Thurnheer, Martin D Weltman

171

Publications

11.4K

Citations

H-Index

101

Concepts

All Affiliations

Nepean Hospital The University of Sydney UNSW Sydney Westmead Hospital Westmead Institute

About

Martin Weltman is an author at Nepean Hospital specializing in medicine, hepatitis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	5K
2	Health Sciences	9	9	2.5K
3	Public Health	5	5	422
4	Arts	1	1	119
5	Social Sciences	1	1	25

Martin Weltman

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C. Farrell, Hepatology Metabolic DisorderInsulin Resistance SyndromeInsulin HypersecretionFatty Liver DiseaseInsulin Signaling	2002	1.1K
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Martin Weltman, Geoffrey C. Farrell, Pauline de la Μ. Hall, Hepatology ImmunologyGastroenterologyPathologyCompatible Liver HistologyFatty Liver Disease	1998	610
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study Natasha A. Koloski, Michael Jones, Jamshid S. Kalantar, Gut	2012	583
Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell, Gastroenterology Metabolic Associated SteatohepatitisFibrosisHepatologyNonalcoholic Fatty Liver DiseaseLiver Physiology	2007	477
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma Jason Behary, Nadia Amorim, Xiaotao Jiang, Nature Communications	2021	432
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial Jason Grebely, Olav Dalgård, Brian Conway, The Lancet. Gastroenterology & hepatology HepatologyHepatitis CTreatment And PreventionViral HepatitisPhase 4	2018	286
HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity Shivakumar Chitturi, Martin Weltman, Geoffrey C. Farrell, Hepatology	2002	246
Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment Martin Weltman, Agus E Brotodihardjo, Evelyn Crewe, Journal of Viral Hepatitis	1995	181
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study Vijayaprakash Suppiah, Silvana Gaudieri, Nicola J. Armstrong, PLoS Medicine	2011	180

Page 1